Prolonging life and suffering

Holm, R.P.

South Dakota Medicine the Journal of the South Dakota State Medical Association 67(5): 208

2014


ISSN/ISBN: 0038-3317
PMID: 24860888
Document Number: 672890
2013 saw few therapeutic innovations that really benefitted patients; once again, marketing authorisations were too often granted despite inadequate clinical data. The French health authorities implemented a few measures designed to protect patients from dangerous drugs, including market withdrawals, restrictions on use, and delisting.

Document emailed within 1 workday
Secure & encrypted payments